Reading Cannabis Company Filings: SEC vs SEDAR+, Going Concern, Debt Maturities and Uncertain Tax Positions

This guide is for investors and business owners who want to read a cannabis company’s own reports instead of relying on headlines or promoters. You will learn where U.S. and Canadian cannabis companies file, which sections carry the most weight, how to spot going-concern doubts and looming debt maturities, and how to read the uncertain tax position disclosures that 280E created. It uses real filings as worked examples, not as recommendations.
This article is for education only and is not investment, legal, or tax advice. Investing involves risk, including loss of principal.
- Many U.S. cannabis operators file in two places: SEC EDGAR in the U.S. and SEDAR+ in Canada. Check both, and note which documents are audited.
- Read the auditor’s report first. Under PCAOB standards, a going-concern paragraph means the auditor has substantial doubt the company can keep operating for up to one year beyond the balance sheet date.
- The debt note and the uncertain tax position note are where cannabis-specific risk usually sits. Some operators carry hundreds of millions of dollars in liabilities for disputed 280E taxes.
- In 2026 filings, look for how each company treats the April 2026 rescheduling order in its tax provision, and whether it splits medical and adult-use results.
Table of Contents
Where cannabis companies file: SEC EDGAR and SEDAR+
Because many U.S. multi-state operators were organized in Canada or listed on the Canadian Securities Exchange, their documents often live in two systems.
- SEC EDGAR holds U.S. filings: annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and proxy statements. EDGAR’s full-text search lets you look for phrases such as “280E,” “going concern” or “uncertain tax position” across all filers.
- SEDAR+ is the Canadian Securities Administrators’ filing and search system. According to the CSA, it launched on July 25, 2023, replacing the original SEDAR system as well as the national cease trade order and disciplined list databases. Canadian reporting issuers post their financial statements, management’s discussion and analysis, press releases and material documents there.
A company that reports in both countries may file substantially the same annual report in both, but not always at the same time or in the same format. If a filing appears on one system and not the other, find out why. Late filings, cease trade orders and auditor changes are all worth noting, and SEDAR+ includes the cease trade order records.
Smaller cannabis companies may not file with the SEC at all. If a company’s shares are quoted over the counter and it publishes nothing audited, you are relying on whatever it chooses to say. The SEC’s investor alert on marijuana investments warns that information about small companies can be scarce, which makes manipulation easier.
A reading order that saves time
A cannabis 10-K can run to hundreds of pages, much of it boilerplate about federal law. This order gets you to the useful parts quickly:
- Auditor’s report (at the start of the financial statements). Is the opinion clean? Is there a going-concern paragraph or a critical audit matter about taxes or impairments?
- Balance sheet. Cash, current liabilities, total debt, and any line for “uncertain tax position liabilities” or “income taxes payable.”
- Cash flow statement. Operating cash flow versus capital spending, and how much cash flow comes from simply not paying tax that is in dispute.
- Debt note. Maturities by year, interest rates, covenants and security.
- Income tax note. Effective tax rate reconciliation and the unrecognized tax benefits table.
- Risk factors and legal proceedings. Rescheduling, litigation, IRS audits, state license issues.
- MD&A. Management’s explanation, which you can now test against the numbers you have already read.
Our beginner’s guide on how to read a 10-K walks through each section in general terms.
Going-concern language
PCAOB auditing standard AS 2415 requires the auditor of a public company to evaluate whether there is substantial doubt about the company’s ability to continue as a going concern for a reasonable period, defined as no more than one year beyond the date of the audited financial statements. If substantial doubt remains after considering management’s plans, the auditor must add an explanatory paragraph that uses the words “substantial doubt” and “going concern.”
In cannabis, the conditions that lead to that paragraph tend to be:
- debt coming due within the year with no committed refinancing;
- large tax liabilities, including 280E amounts under IRS audit, that could become payable;
- recurring operating losses and negative operating cash flow; and
- covenant breaches, defaults or forbearance agreements with lenders.
A going-concern paragraph is not a prediction that the company will fail. It does tell you the auditor could not get comfortable without new money or changes, which usually means dilution, expensive debt, asset sales or restructuring. Also read management’s own going-concern disclosure in the notes, which describes its plans. If those plans depend on a law changing, treat them with caution.
Debt maturities and financing terms
Cannabis operators have had limited access to bank loans and U.S. exchanges, so many rely on private notes, convertible debt, sale-leaseback arrangements and specialty lenders. These usually cost more than ordinary corporate borrowing. Lenders’ own filings acknowledge this: one cannabis-focused mortgage REIT said in its 2025 10-K that it benefits from the industry’s constrained access to U.S. capital markets.
In the debt note, look for:
- The maturity schedule. A table of principal due in each of the next five years. A large amount due in the next 12 to 24 months is a refinancing test.
- Interest rates and fees. Including payment-in-kind interest, which adds to principal instead of being paid in cash.
- Covenants. Minimum cash, leverage or EBITDA tests, and whether any were amended or waived.
- Security and guarantees. Which subsidiaries and licenses are pledged.
- Convertibles and warrants. Conversion prices tell you how many new shares could appear.
- Lease-like liabilities. Sale-leasebacks may appear as “construction finance liabilities” or finance obligations rather than debt. One large operator’s 2025 balance sheet carried separate lines for private placement notes, notes payable, operating leases, finance leases and construction finance liabilities. Add them up to see total fixed obligations.
Illustrative example: a company reports $50 million in cash, $20 million in annual operating cash flow and $120 million of notes due in 18 months. Even if all $20 million is saved, it will have about $50 + ($20 × 1.5) = $80 million when the notes come due, leaving a $40 million gap to refinance, extend or cover with new equity. The going-concern note and subsequent-events note will tell you whether it has a plan.
Uncertain tax positions and 280E
Section 280E bars deductions and credits for businesses trafficking in Schedule I or II substances. Many operators have taken the position on their returns that 280E does not stop them from deducting ordinary business expenses. Accounting rules (ASC 740) require a company to record a tax benefit only if the position is more likely than not to be sustained. When a company files its return one way but cannot meet that threshold, it records a liability for the tax it may owe. That is the “uncertain tax position” liability.
The amounts can be very large. One multi-state operator’s 2025 10-K shows how this works:
- The company states that the IRS position is that 280E allows cannabis companies to deduct essentially only cost of goods sold, and that the company has taken the opposite position on its returns.
- Its balance sheet showed uncertain tax position liabilities of about $668.4 million at December 31, 2025, up from about $445.2 million a year earlier.
- Its 2025 effective tax rate was 227.5%, against a 21% federal statutory rate, mostly because of increases in unrecognized tax benefits.
- In legal proceedings, it disclosed that the IRS issued Revenue Agent Reports in September 2025 proposing taxes, interest and penalties for some subsidiaries. The company said it was protesting them before the IRS Independent Office of Appeals and that proposed penalties of about $38.1 million were not included in its recorded liability.
What to take from a disclosure like this:
- Cash flow may be flattered. Unpaid disputed tax shows up as an addition to operating cash flow. In the same 10-K, the increase in uncertain tax position liabilities was one of the largest reconciling items in operating cash flow. If the IRS wins, that cash goes out the door.
- Interest keeps accruing. Even after the tax law changes going forward, interest on past positions continues.
- Look for audit status. Revenue Agent Reports, appeals and Tax Court petitions are signs a dispute is getting closer to resolution, one way or the other.
Our explainer on rescheduling and 280E sets out the illustrative tax math and current federal status.
What changed in 2026 filings
The April 28, 2026 order placed state-licensed medical marijuana in Schedule III and said medical licensees are no longer subject to 280E. Treasury and the IRS have announced guidance, including a transition rule covering the full taxable year that includes the effective date, but as of November 19, 2026 we found no published guidance. Adult-use activity remains Schedule I.
2026 quarterly reports show companies working through this. The same operator’s 10-Q for the quarter ended September 30, 2026 says:
- it based its 2026 tax provision on the Treasury and IRS announcement and the order, and is not applying 280E for the 2026 tax year;
- its uncertain tax position liabilities were still about $625.4 million at September 30, 2026, because the earlier years remain in dispute; and
- its effective tax rate for that quarter was 97%, which it attributed mainly to interest on uncertain tax positions from prior years.
The same filing describes a June 2026 transaction that moved the company’s former mixed medical and adult-use operations into an entity it no longer controls, so that the listed company is medical-only. Restructurings like this change revenue, assets and debt, sometimes dramatically, so compare periods with care and read the disposition note.
When you read any 2026 cannabis filing, ask:
- Does the company separate medical and adult-use revenue and expenses?
- Has it stopped applying 280E, and to which activities? What happens to the provision if the guidance or the courts go the other way?
- Does it describe the D.C. Circuit challenge to the April order as a risk?
- Has it applied for and received DEA registrations under the expedited process?
A checklist
| Item | Where to find it | Warning sign |
|---|---|---|
| Auditor opinion | Start of the financial statements | Going-concern paragraph; recent auditor change |
| Cash and near-term debt | Balance sheet; debt note | Debt due within 12 to 24 months greater than cash plus realistic cash flow |
| Uncertain tax positions | Balance sheet; income tax note | Large and growing liability; IRS audit reports or penalties |
| Effective tax rate | Income tax note | Far above the statutory rate with no clear explanation |
| Share count | Equity note; cover page | Rapid growth from conversions, warrants or equity raises |
| Medical vs adult-use mix | Segment or revenue note; MD&A | No breakdown despite major tax and legal differences |
| Filing history | EDGAR and SEDAR+ | Late filings; cease trade orders |
The same habits work for hemp and CBD companies, with different legal risks. See our guide to evaluating hemp companies, and for a private business, our due diligence checklist.
Frequently asked questions
Why do some cannabis companies file on both EDGAR and SEDAR+?
Many were organized in Canada or listed on a Canadian exchange while operating in the U.S., so they are reporting issuers in both countries. Check both systems for the complete record.
What is an uncertain tax position in a cannabis filing?
It is a liability for tax the company may owe because it took a position on its return, often that 280E does not limit its deductions, that it cannot say is more likely than not to hold up. If the IRS prevails, the company owes the tax plus interest and possibly penalties.
Does rescheduling erase past 280E liabilities?
No. As of November 19, 2026, the April 2026 order and Treasury’s announcement point to relief starting with the tax year that includes April 28, 2026, for medical activity. Retroactive relief for earlier years has been requested but not granted.
How far ahead does a going-concern evaluation look?
Under PCAOB AS 2415, the auditor considers a reasonable period of up to one year beyond the date of the financial statements being audited.
Where can I search all cannabis filings for a phrase?
SEC EDGAR full-text search covers U.S. filings and lets you filter by form type and date. SEDAR+ has its own search for Canadian filings.
Rules and company structures in this sector are changing quickly. Always read the most recent filing before relying on an older one.
Sources
Credit: the facts, figures and rules in this article come from the organizations and authors listed below. All credit for their research and data belongs to them; follow the links to read the originals.
- Canadian Securities Administrators, About SEDAR+ (2023)
- U.S. Securities and Exchange Commission, EDGAR Full-Text Search
- PCAOB, AS 2415: Consideration of an Entity’s Ability to Continue as a Going Concern
- SEC Office of Investor Education and Advocacy, Investor Alert: Marijuana Investments and Fraud (2018)
- Trulieve Cannabis Corp., Form 10-K for fiscal year 2025, SEC EDGAR (2026)
- Trulieve Cannabis Corp., Form 10-Q for the quarter ended September 30, 2026, SEC EDGAR (2026)
- Chicago Atlantic Real Estate Finance, Inc., Form 10-K for fiscal year 2025, SEC EDGAR (2026)
- U.S. Department of Justice / DEA, Final Rule: Rescheduling of FDA-Approved Products Containing Marijuana and State-Licensed Medical Marijuana to Schedule III, 91 FR 22714 (2026)
- U.S. Department of the Treasury, Treasury, IRS Announce Process for Tax Guidance Following DOJ Final Order on Medical Marijuana Rescheduling (2026)
- 26 U.S.C. § 280E, Expenditures in connection with the illegal sale of drugs (Legal Information Institute)
Figures last checked: November 19, 2026.
🌱 Finished reading? You earned 5 seeds.
Every article you read to the end earns seeds in Hemp Empire, our free hemp farming tycoon game. Play now →
Some links may be affiliate links. As an Amazon Associate, HempDollars earns from qualifying purchases.


Leave a Reply